1. Home
  2. PCVX vs EHC Comparison

PCVX vs EHC Comparison

Compare PCVX & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • EHC
  • Stock Information
  • Founded
  • PCVX 2013
  • EHC 1983
  • Country
  • PCVX United States
  • EHC United States
  • Employees
  • PCVX N/A
  • EHC N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • EHC Hospital/Nursing Management
  • Sector
  • PCVX Health Care
  • EHC Health Care
  • Exchange
  • PCVX Nasdaq
  • EHC Nasdaq
  • Market Cap
  • PCVX 4.0B
  • EHC 12.4B
  • IPO Year
  • PCVX 2020
  • EHC 1986
  • Fundamental
  • Price
  • PCVX $42.33
  • EHC $126.42
  • Analyst Decision
  • PCVX Strong Buy
  • EHC Strong Buy
  • Analyst Count
  • PCVX 8
  • EHC 8
  • Target Price
  • PCVX $114.17
  • EHC $140.63
  • AVG Volume (30 Days)
  • PCVX 1.8M
  • EHC 605.0K
  • Earning Date
  • PCVX 11-05-2025
  • EHC 10-29-2025
  • Dividend Yield
  • PCVX N/A
  • EHC 0.60%
  • EPS Growth
  • PCVX N/A
  • EHC 30.39
  • EPS
  • PCVX N/A
  • EHC 5.11
  • Revenue
  • PCVX N/A
  • EHC $5,669,100,000.00
  • Revenue This Year
  • PCVX N/A
  • EHC $11.57
  • Revenue Next Year
  • PCVX N/A
  • EHC $8.79
  • P/E Ratio
  • PCVX N/A
  • EHC $24.61
  • Revenue Growth
  • PCVX N/A
  • EHC 11.80
  • 52 Week Low
  • PCVX $27.66
  • EHC $87.85
  • 52 Week High
  • PCVX $116.00
  • EHC $127.99
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 60.91
  • EHC 59.35
  • Support Level
  • PCVX $41.24
  • EHC $124.04
  • Resistance Level
  • PCVX $43.45
  • EHC $125.63
  • Average True Range (ATR)
  • PCVX 1.71
  • EHC 2.06
  • MACD
  • PCVX -0.33
  • EHC 0.21
  • Stochastic Oscillator
  • PCVX 40.24
  • EHC 86.55

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Share on Social Networks: